Novavax Inc
NVAX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001000694
No open-market purchases or sales by Novavax Inc insiders were filed in the last 90 days; 267 institutions reported holding it in 13F filings for Q2 2026, worth $1.11B in total; Coatue Management is the only superinvestor holding it.
Holders of 5% or more of NVAX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Novavax Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Shah Capital Management | 13D/A | 9.03%14.8M shares | −0.08 ppfrom 9.11% | Oct 14, 20254 filings | May 15, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 8.40%13.5M shares | – | Feb 5, 20251 filing | Feb 5, 2025 | SEC |
| State Street Corp | 13G | 7.10%11.7M shares | +1.20 ppfrom 5.90% | Feb 2, 20233 filings | Aug 7, 2026 | SEC |
| Vanguard Capital Management LLC | 13G | 5.09%8.31M shares | New | Apr 30, 20261 filing | Apr 30, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
22 Schedule 13D and 13G filings on Novavax Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 202610:26 AM ET | State Street Corp | 13G | 7.10%11.7M shares | +1.20 ppfrom 5.90% | Jun 30, 2026 | SEC |
| May 15, 20268:15 AM ET | Shah Capital Managementand 2 others | 13D/A | 9.03%14.8M shares | −0.08 ppfrom 9.11% | May 14, 2026 | SEC |
| Apr 30, 202612:07 PM ET | Vanguard Capital Management LLC | 13G | 5.09%8.31M shares | New | Mar 31, 2026 | SEC |
| Apr 27, 20261:02 PM ET | Bank of America Corp | 13G/A | 4.10%6.66M shares | −1.00 ppfrom 5.10%Below 5% | Mar 31, 2026 | SEC |
| Apr 8, 20266:00 AM ET | Shah Capital Managementand 2 others | 13D/A | 9.11%14.8M shares | +0.81 ppfrom 8.30% | Apr 8, 2026 | SEC |
| Mar 27, 202611:06 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Feb 11, 20262:11 PM ET | Bank of America Corp | 13G | 5.10%8.32M shares | New | Dec 31, 2025 | SEC |
| Feb 9, 20267:56 AM ET | State Street Corp | 13G | 5.90%9.52M shares | – | Dec 31, 2025 | SEC |
| Nov 12, 20254:17 PM ET | Shah Capital Managementand 2 others | 13D/A | 8.30%13.5M shares | +1.00 ppfrom 7.30% | Nov 10, 2025 | SEC |
| Oct 14, 20257:45 AM ET | Shah Capital Managementand 2 others | 13D/A | 7.30%11.8M shares | – | Oct 13, 2025 | SEC |
| Feb 5, 20251:23 PM ET | BlackRock, Inc. | 13G/A | 8.40%13.5M shares | – | Dec 31, 2024 | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 2, 2023 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Dec 12, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Mar 11, 20222:13 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 8, 20225:05 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Feb 16, 2021 | Ra Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | D. E. Shaw & Co, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Feb 5, 20217:51 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Novavax Inc shares.
No Form 144 notices for Novavax Inc are on file.